Author

Collin Jugler

Mayo Clinic ArizonaORCID 0000-0001-9207-7539Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Casey R AgeriD· 1 shared Fan Shen· 1 shared Feda H Hamdan· 1 shared Haidar M Abdul-Muhsin· 1 shared Jack R Andrews· 1 shared Jarl F Carnahan· 1 shared Jessica C Hill· 1 shared Jessica N Lancaster· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Casey R AgerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintNov 11, 2026

Cytotoxic CD4+ exTregs expressing KLRG1 retain immunosuppressive function in cancer

Collin Jugler, Kade R Copple, Jessica C Hill…·Casey R Ager

This study identifies KLRG1+ cytotoxic CD4+ T cells in tumors that retain immunosuppressive function, derived from Tregs, and suggests KLRG1-targeted depletion may be more effective than blockade in cancer therapy.

DOI 10.64898/2026.11.09.765461

mousehuman

𝕏 PostBluesky